Acadia Pharmaceuticals reported $0 in Debt for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
ALKERMES ALKS:US $ 294.54M 0.63M
Alnylam Pharmaceuticals ALNY:US $ 677.72M 1.01M
Aptinyx Inc APTX:US $ 24.5M 206K
Biogen BIIB:US $ 7277.2M 2M
Biomarin Pharmaceutical BMRN:US $ 1081.05M 0.99M
Bristol Myers Squibb BMY:US $ 42060M 2912M
Cara Therapeutics CARA:US $ 0 0
Corcept Therapeutics CORT:US $ 0M 0M
Cytokinetics CYTK:US $ 199.42M 1.44M
Eisai 4523:JP Y 94902M 9M
Eli Lilly And LLY:US $ 16813.8M 305M
Intercept Pharmaceuticals ICPT:US $ 713.86M 3.03M
Intra Cellular Therapies ITCI:US $ 0M 0M
Marinus Pharmaceuticals MRNS:US $ 70.35M 0.42M
Moderna Inc MRNA:US 762M 44M
Neurocrine Biosciences NBIX:US $ 169M 208.7M
Prothena PRTA:US $ 0M 0M
Ptc Therapeutics PTCT:US $ 1207.54M 10.46M
Sarepta Therapeutics SRPT:US $ 1100.87M 2.03M
Seattle Genetics SGEN:US $ 0M 0M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 482.3M 13.2M
YTE INCY:US $ 34.19M 0.01M